Zhi Ming Selected Research

Zhi Ming Research Topics

6	Insulin Resistance 09/2011 - 02/2006
4	Hyperlipidemias (Hyperlipidemia) 08/2015 - 10/2009
4	Hyperglycemia 08/2015 - 10/2009
4	Hyperinsulinism (Hyperinsulinemia) 08/2015 - 10/2009
3	Obesity 09/2011 - 10/2009
2	Hepatorenal Syndrome 11/2010 - 01/2002
1	Hypoxia (Hypoxemia) 05/2021
1	Stroke (Strokes) 05/2021
1	Reperfusion Injury 05/2021
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Infections 02/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2008
1	Type 2 Diabetes Mellitus (MODY) 08/2008
1	Hemorrhage 11/2006
1	Renal Insufficiency (Renal Failure) 10/2006
1	Fibrosis (Cirrhosis) 10/2006
1	Liver Cirrhosis (Hepatic Cirrhosis) 05/2005

5	Adenosine (Adenocard)FDA LinkGeneric 05/2021 - 01/2002
5	Insulin (Novolin)FDA Link 09/2011 - 11/2006
3	Atropine FDA LinkGeneric 09/2011 - 02/2006
3	AntioxidantsIBA 03/2010 - 08/2008
2	Sucrose (Saccharose)IBA 03/2010 - 10/2009
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 10/2006 - 05/2005
1	Propidium (Propidium Iodide)IBA 05/2021
1	Dynamins (Dynamin)IBA 05/2021
1	CalciumIBA 05/2021
1	perampanelIBA 05/2021
1	Peptides (Polypeptides)IBA 05/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2019
1	Free RadicalsIBA 08/2015
1	Glucose (Dextrose)FDA LinkGeneric 08/2015
1	Neurotransmitter Agents (Neurotransmitter)IBA 02/2015
1	DiureticsIBA 11/2010
1	Caffeine (No Doz)FDA LinkGeneric 11/2010
1	EnzymesIBA 02/2006
1	VitaminsIBA 02/2006
1	SodiumIBA 01/2002

1	Therapeutics 05/2021
1	Drug Therapy (Chemotherapy) 01/2019